skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 23,668  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Humans remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Principles of early drug discovery
Material Type:
Article
Add to My Research

Principles of early drug discovery

British journal of pharmacology, 2011-03, Vol.162 (6), p.1239-1249 [Peer Reviewed Journal]

2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society ;2015 INIST-CNRS ;2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society. ;British Journal of Pharmacology © 2011 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2010.01127.x ;PMID: 21091654 ;CODEN: BJPCBM

Full text available

2
Biodegradation of Alprazolam in Pharmaceutical Wastewater Using Mesoporous Nanoparticles-Adhered Pseudomonas stutzeri
Material Type:
Article
Add to My Research

Biodegradation of Alprazolam in Pharmaceutical Wastewater Using Mesoporous Nanoparticles-Adhered Pseudomonas stutzeri

Molecules (Basel, Switzerland), 2021-12, Vol.27 (1), p.237 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules27010237 ;PMID: 35011469

Full text available

3
Drug repurposing: progress, challenges and recommendations
Material Type:
Article
Add to My Research

Drug repurposing: progress, challenges and recommendations

Nature reviews. Drug discovery, 2019-01, Vol.18 (1), p.41-58 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2018.168 ;PMID: 30310233

Full text available

4
Human organs-on-chips for disease modelling, drug development and personalized medicine
Material Type:
Article
Add to My Research

Human organs-on-chips for disease modelling, drug development and personalized medicine

Nature reviews. Genetics, 2022-08, Vol.23 (8), p.467-491 [Peer Reviewed Journal]

2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;Springer Nature Limited 2022 ;ISSN: 1471-0056 ;EISSN: 1471-0064 ;DOI: 10.1038/s41576-022-00466-9 ;PMID: 35338360

Full text available

5
Viral targets for vaccines against COVID-19
Material Type:
Article
Add to My Research

Viral targets for vaccines against COVID-19

Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022

Full text available

6
High-performance medicine: the convergence of human and artificial intelligence
Material Type:
Article
Add to My Research

High-performance medicine: the convergence of human and artificial intelligence

Nature medicine, 2019-01, Vol.25 (1), p.44-56 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0300-7 ;PMID: 30617339

Full text available

7
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Material Type:
Article
Add to My Research

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature reviews. Drug discovery, 2017-08, Vol.16 (8), p.531-543 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2017.111 ;PMID: 28685762

Full text available

8
Applications of machine learning in drug discovery and development
Material Type:
Article
Add to My Research

Applications of machine learning in drug discovery and development

Nature reviews. Drug discovery, 2019-06, Vol.18 (6), p.463-477 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Springer Nature Limited 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0024-5 ;PMID: 30976107

Full text available

9
Natural products in drug discovery: advances and opportunities
Material Type:
Article
Add to My Research

Natural products in drug discovery: advances and opportunities

Nature reviews. Drug discovery, 2021-03, Vol.20 (3), p.200-216 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-020-00114-z ;PMID: 33510482

Full text available

10
The practical implementation of artificial intelligence technologies in medicine
Material Type:
Article
Add to My Research

The practical implementation of artificial intelligence technologies in medicine

Nature medicine, 2019-01, Vol.25 (1), p.30-36 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0307-0 ;PMID: 30617336

Full text available

11
RNA therapeutics on the rise
Material Type:
Article
Add to My Research

RNA therapeutics on the rise

Nature reviews. Drug discovery, 2020-07, Vol.19 (7), p.441-442 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00078-0 ;PMID: 32341501

Full text available

12
Trends in GPCR drug discovery: new agents, targets and indications
Material Type:
Article
Add to My Research

Trends in GPCR drug discovery: new agents, targets and indications

Nature reviews. Drug discovery, 2017-12, Vol.16 (12), p.829-842 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2017 ;ISSN: 1474-1776 ;ISSN: 1474-1784 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2017.178 ;PMID: 29075003

Full text available

13
Precision Medicine — Personalized, Problematic, and Promising
Material Type:
Article
Add to My Research

Precision Medicine — Personalized, Problematic, and Promising

The New England journal of medicine, 2015-06, Vol.372 (23), p.2229-2234 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb1503104 ;PMID: 26014593

Full text available

14
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Material Type:
Article
Add to My Research

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

The Lancet (British edition), 2022-02, Vol.399 (10325), p.629-655 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2022 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02724-0 ;PMID: 35065702

Full text available

15
Embolic strokes of undetermined source: the case for a new clinical construct
Material Type:
Article
Add to My Research

Embolic strokes of undetermined source: the case for a new clinical construct

Lancet neurology, 2014-04, Vol.13 (4), p.429-438 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(13)70310-7 ;PMID: 24646875 ;CODEN: LANCAO

Full text available

16
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Material Type:
Article
Add to My Research

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

The lancet oncology, 2017-03, Vol.18 (3), p.e143-e152 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 01, 2017 ;2017. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30074-8 ;PMID: 28271869 ;CODEN: LANCAO

Full text available

17
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Material Type:
Article
Add to My Research

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

The lancet oncology, 2016-12, Vol.17 (12), p.e542-e551 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30406-5 ;PMID: 27924752 ;CODEN: LANCAO

Full text available

18
Looking beyond COVID-19 vaccine phase 3 trials
Material Type:
Article
Add to My Research

Looking beyond COVID-19 vaccine phase 3 trials

Nature medicine, 2021-02, Vol.27 (2), p.205-211 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01230-y ;PMID: 33469205

Full text available

19
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Material Type:
Article
Add to My Research

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

The lancet oncology, 2016-11, Vol.17 (11), p.1497-1508 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30498-3 ;PMID: 27745820 ;CODEN: LANCAO

Full text available

20
SARS-CoV-2 vaccines in development
Material Type:
Article
Add to My Research

SARS-CoV-2 vaccines in development

Nature (London), 2020-10, Vol.586 (7830), p.516-527 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2798-3 ;PMID: 32967006

Full text available

Results 1 - 20 of 23,668  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (22,545)

Refine My Results

Creation Date 

From To
  1. Before 1978  (17)
  2. 1978 To 1989  (631)
  3. 1990 To 2000  (2,998)
  4. 2001 To 2012  (10,412)
  5. After 2012  (9,612)
  6. More options open sub menu

Language 

  1. English  (23,661)
  2. Japanese  (3,291)
  3. Portuguese  (53)
  4. French  (28)
  5. Norwegian  (12)
  6. German  (6)
  7. Italian  (3)
  8. Chinese  (3)
  9. Swedish  (2)
  10. Dutch  (2)
  11. Welsh  (1)
  12. Russian  (1)
  13. Serbian  (1)
  14. Spanish  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait